Paper830792
Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.
Takahashi M and 2 others. J Exp Med, 1977. Cited by 110 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. Papers, record 830792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/830792
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen-Antibody Complex | Major topic |
| Complement C3 | Major topic |
| Complement System Proteins | Major topic |
| Properdin | Major topic |
| Kinetics | |
| Magnesium | |
| Temperature |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,160,044 | A method of trace iodination of proteins for immunologic studies. | Int Arch Allergy Appl Immunol | 1966 | https://conductscience.org/library/papers/4160044 | PubMed |
| 2 | 4,169,693 | Properties of highly purified human properdin. | J Immunol | 1968 | https://conductscience.org/library/papers/4169693 | PubMed |
| 3 | 2,647 | Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement. | J Exp Med | 1976 | https://conductscience.org/library/papers/2647 | PubMed |
| 4 | 4,477,550 | Studies on the sub-unit structure of human properdin. | Immunochemistry | 1974 | https://conductscience.org/library/papers/4477550 | PubMed |
| 5 | 4,808,709 | The role of properdin in the alternate pathway of complement activation. | J Exp Med | 1974 | https://conductscience.org/library/papers/4808709 | PubMed |
| 6 | 4,795,621 | The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway. | J Immunol | 1973 | https://conductscience.org/library/papers/4795621 | PubMed |
| 7 | 4,738,906 | Solid phase radioimmunoassay of properdin. | Immunochemistry | 1973 | https://conductscience.org/library/papers/4738906 | PubMed |
| 8 | 4,953,701 | Antibody-complement complexes. | Science | 1965 | https://conductscience.org/library/papers/4953701 | PubMed |
| 9 | 1,094,920 | Complement. | Annu Rev Biochem | 1975 | https://conductscience.org/library/papers/1094920 | PubMed |
| 10 | 1,054,824 | A new complement function: solubilization of antigen-antibody aggregates. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1054824 | PubMed |
| 11 | 1,059,108 | Properdin: initiation of alternative complement pathway. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1059108 | PubMed |
| 12 | 1,249,522 | Studies on the mechanism of solubilization of immune precipitates by serum. | J Exp Med | 1976 | https://conductscience.org/library/papers/1249522 | PubMed |
| 13 | 1,165,475 | Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor. | J Exp Med | 1975 | https://conductscience.org/library/papers/1165475 | PubMed |
| 14 | 5,778,786 | Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. | J Exp Med | 1969 | https://conductscience.org/library/papers/5778786 | PubMed |
| 15 | 6,019,133 | Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. | J Exp Med | 1967 | https://conductscience.org/library/papers/6019133 | PubMed |
| 16 | 5,912,034 | Reversible adsorption of C'2 by EAC'4: role of Mg2+, enumeration of competent SAC'4, two-step nature of C'2a fixation and estimation of its efficiency. | Immunochemistry | 1966 | https://conductscience.org/library/papers/5912034 | PubMed |
| 17 | 14,280,442 | C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT. | J Exp Med | 1965 | https://conductscience.org/library/papers/14280442 | PubMed |
| 18 | 14,097,352 | THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. | Biochem J | 1963 | https://conductscience.org/library/papers/14097352 | PubMed |
| 20 | 823,964 | Third component of human complement: purification from plasma and physicochemical characterization. | Biochemistry | 1976 | https://conductscience.org/library/papers/823964 | PubMed |
| 21 | 790,687 | Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology. | Transplant Rev | 1976 | https://conductscience.org/library/papers/790687 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,996,342 | Minimal role for the alternative pathway in complement activation by HIT immune complexes. | J Thromb Haemost | 2022 | https://conductscience.org/library/papers/35996342 | PubMed |
| 31,217,324 | Follicular B2 Cell Activation and Class Switch Recombination Depend on Autocrine C3ar1/C5ar1 Signaling in B2 Cells. | J Immunol | 2019 | https://conductscience.org/library/papers/31217324 | PubMed |
| 29,114,042 | Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy. | J Am Soc Nephrol | 2018 | https://conductscience.org/library/papers/29114042 | PubMed |
| 18,821,684 | Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. | Arthritis Rheum | 2008 | https://conductscience.org/library/papers/18821684 | PubMed |
| 12,869,025 | Immune complex-FcgammaR interaction modulates monocyte/macrophage molecules involved in inflammation and immune response. | Clin Exp Immunol | 2003 | https://conductscience.org/library/papers/12869025 | PubMed |
| 7,316,962 | The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. | Biochem J | 1981 | https://conductscience.org/library/papers/7316962 | PubMed |
| 7,307,341 | Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7307341 | PubMed |
| 7,305,917 | Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin. | Biochem J | 1981 | https://conductscience.org/library/papers/7305917 | PubMed |
| 7,275,185 | Enhancement of monocyte complement component synthesis by antigen--antibody complexes. | Immunology | 1981 | https://conductscience.org/library/papers/7275185 | PubMed |
| 6,979,449 | Complement-mediated solubilization of immune complexes in systemic lupus erythematosus. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6979449 | PubMed |
| 6,979,442 | Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6979442 | PubMed |
| 6,832,806 | Molecular composition of complement-solubilized complexes and their fate in vivo. | Immunology | 1983 | https://conductscience.org/library/papers/6832806 | PubMed |
| 6,822,408 | Molecular distribution of preformed thyroglobulin immune complexes. | Immunology | 1983 | https://conductscience.org/library/papers/6822408 | PubMed |
| 6,480,828 | Complement depletion accelerates the clearance of immune complexes from the circulation of primates. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6480828 | PubMed |
| 6,447,230 | Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/6447230 | PubMed |
| 6,364,431 | The role of antibody in the activation of the alternative complement pathway. | Springer Semin Immunopathol | 1983 | https://conductscience.org/library/papers/6364431 | PubMed |
| 6,333,948 | Prevention of immune precipitation by purified classical pathway complement components. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6333948 | PubMed |
| 6,282,506 | Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6282506 | PubMed |
| 6,270,189 | Difference in antibody reactivity between complement fixation and immune adherence hemagglutination tests with virus antigens. | J Clin Microbiol | 1981 | https://conductscience.org/library/papers/6270189 | PubMed |
| 6,220,848 | Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6220848 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| CFP | 5,199 | PubTator's text mining | https://conductscience.org/library/genes/5199 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/830792
GET https://conductscience.org/api/papers/v1/830792/references?page=2